Coverage and analysis of Taiwan-based Foxconn’s announcement that it will invest $10 billion to build an electronic display-making plant in Wisconsin has dominated business news around the state lately.

However, there have also been numerous notable happenings apart from the Foxconn saga. Let’s catch up on some of them:

—Cellular Dynamics International scrapped plans to construct a new, 100,000-square-food headquarters several miles from its current home in Madison, the Wisconsin State Journal reported. The stem cell provider made public its intention to relocate to Verona, a suburb of Madison, late last year. CDI, a subsidiary of Tokyo-based Fujifilm, had reportedly obtained up to $6 million in financial incentives from the city of Verona. However, the company has instead decided to remodel an existing building—location to be determined—and manufacture stem cells there, according to the report.

—Madison-based Invenra, which develops therapeutic antibodies for large pharma companies and other clients, agreed to a partnership with Kenilworth, NJ-based Merck (NYSE: MRK). Under the terms of the agreement, Invenra will discover antibodies against an undisclosed target of interest to Merck. Invenra co-founder and CEO Roland Green declined to comment on specific financial terms of the partnership.

Read the full article here.